Rhythm Pharmaceuticals, Inc. (RYTM)
100.71
-4.47
(-4.25%)
USD |
NASDAQ |
Dec 09, 16:00
101.50
+0.79
(+0.78%)
After-Hours: 07:48
Rhythm Pharmaceuticals Shareholders Equity (Quarterly): 148.82M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 21.54B |
| Terns Pharmaceuticals, Inc. | 284.07M |
| Altimmune, Inc. | 185.60M |
| Viking Therapeutics, Inc. | 713.03M |
| Cidara Therapeutics, Inc. | 422.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 506.87M |
| Total Liabilities (Quarterly) | 358.06M |
| Debt to Equity Ratio | 1.747 |
| Current Ratio | 4.746 |
| Net Debt Paydown Yield | -0.02% |